Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system

ABSTRACT:

SUBMITTER: Wang B 

PROVIDER: S-EPMC12342331 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature